BLUME-JENSEN PETER (President and CEO) received a stock award from ACRIVON THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 5/20/2026ACC: 0000905148-26-002549
DirectorOfficer· President and CEO
Since Mar 2026
+252.80K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
252.80K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+180.09K
Price / share
—
Trade value
—
% of position
8.7%
5/18/2026
2.08M→2.26M
Common Stock
Indirect
Shares
+72.71K
Price / share
—
Trade value
—
% of position
23.2%
5/18/2026
313.64K→386.34K
Total
Net shares
+252.80K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/18/2026 | A · Award | +180.09K | — | — | 8.7% | 2.08M | 2.26M |
| Common Stock Indirect | 5/18/2026 | A · Award | +72.71K | — | — | 23.2% | 313.64K | 386.34K |
| Total | +252.80K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported